- The study has not been peer-reviewed or published in a scientific journal, according to The New York Times. It was, however, published by a group scientists who have no ties to the vaccine developers.
What the study found
- The study primarily found that the Johnson & Johnson vaccine might not protect patients from the delta and lambda variants — two mutations of the novel coronavirus that are known to be highly transmissible.
- The data for the study came through blood samples in a lab, which means the findings might not be a reflection of what’s going on in the real world.
- The study suggested people might need to receive a booster shot from one of the mRNA vaccines — like the ones from Pfizer and Moderna.
Do experts agree?
- “The message that we wanted to give was not that people shouldn’t get the J&J vaccine, but we hope that in the future, it will be boosted with either another dose of J&J or a boost with Pfizer or Moderna,” he said.
- “I have always thought, and often said, that the J&J vaccine is a two-dose vaccine,” he said.
When will there be booster shots?
Vaccine developer Pfizer has been pushing for a booster shot to get approved by health officials. But the Centers for Disease Control and Prevention and the Food and Drug Administration said in a joint statement, “Americans who have been fully vaccinated do not need a booster shot at this time.”
- “There are a number of us that would get in line to get a booster,” he said.
- “How long is it going to take before we’re able to get sufficient information to allow Americans who want to get an additional vaccination to be able to do so? Are we talking weeks? Are we talking months?” Romney asked.
Does Johnson & Johnson have a booster?
Johnson & Johnson has not released any details of a booster shot.